INSIGHTS ON DRUG DEVELOPMENT

DRUG DEVELOPMENT SOLUTIONS

  • We offer a comprehensive method optimization service to take early stage development methods with poor stability indication, excessive run time lengths, or legacy column chemistries and modify them.

  • High-intensity sweeteners can improve palatability across oral dosage forms. Learn more about taste-masking performance, sweetness potency, and solubility to make a more informed excipient selection.

  • DSC and ITC offer deep insights into molecular binding and structural stability, which help researchers uncover thermodynamic drivers and domain-level behavior essential for protein characterization.

  • Learn how harnessing a CDMO’s extensive knowledge and skills in dealing with controlled substances can help you advance your innovative psychedelic therapeutic safely and efficiently.

  • Find what you need to move your Alzheimer’s research forward faster, with antibodies to 95% of core AD genes validated in imaging applications with human samples.